B-Sol

Irrigation Solution
Popular Pharmaceuticals Ltd.
500 ml bottle: ৳ 250.00
Indications

Approved Indication:

  • Extraocular and intraocular irrigation during ocular surgical procedures involving perfusion of the eye, with maximum duration of less than 60 minutes (FDA Access Data)

Clinically Accepted Additional Uses:

  • Irrigation of ear, nose, throat, or ocular surfaces in ENT and ophthalmic microsurgery when physiological irrigants are required (olikla.cz)
  • Cell culture and laboratory tissue preparation as a physiological buffered salt medium for maintaining pH, osmotic pressure, and cell viability (eCFR)
Dosage & Administration

Route of Administration:

  • Topical irrigation only (external or intraocular)
  • Not for intravenous or intramuscular use (FDA Access Data)

Ophthalmic (Surgical) Use:

  • Use aseptic techniques: disinfect stopper, spike container, purge air from tubing (DailyMed)
  • Perfusion should not exceed 60 minutes (FDA Access Data)
  • Single‑patient use only; discard after opening (FDA Access Data)

Laboratory Use:

  • Volume and exposure time depend on experimental requirements
  • Used at ambient temperature according to laboratory protocol
Mechanism of Action (MOA)

BSS is an isotonic electrolyte solution containing sodium, potassium, calcium, magnesium, acetate, and citrate at physiologic pH (~7.0–7.5) and osmolality (~300 mOsm/kg). It mimics the ionic composition of aqueous humor, maintaining cellular hydration, corneal endothelial integrity, and osmotic balance during ocular irrigation. It provides a stable environment for cells and tissues during surgical or laboratory procedures, without pharmacologic activity (medtigo.com, Wikipedia).

Pharmacokinetics
  • Absorption & Distribution: Not systemically absorbed; remains local to irrigation site
  • Metabolism & Excretion: Not applicable (no systemic uptake)
  • Onset of Action: Immediate upon contact
  • Bioavailability & Half‑Life: Not relevant for topical use
Pregnancy Category & Lactation
  • Pregnancy: Not systemically administered; no systemic exposure expected. Minimal risk during ophthalmic use.
  • Lactation: Not relevant; no transfer into breast milk occurs via topical intraocular irrigation.
Therapeutic Class
  • Primary Class: Ophthalmic Irrigating Solution
  • Subclass: Balanced Salt Solution matching physiological aqueous humor
Contraindications
  • Not for injection or intravenous infusion; intended strictly for topical irrigation (FDA Access Data, FDA Report)
  • Do not use if container is damaged, seal broken, overwrap compromised, or solution is discolored or has precipitate (FDA Access Data)
  • Single-patient use only; reuse is contraindicated (FDA Access Data, DailyMed)
Warnings & Precautions
  • Strictly not for injection; misuse may lead to fluid overload or electrolyte imbalance (FDA Access Data, FDA Report)
  • Use under aseptic conditions only
  • Use with caution in diabetic patients undergoing vitrectomy, as intraoperative lens changes or corneal effects have been reported (DailyMed)
  • Do not add supplements or medications unless compatibility is verified—additives may cause corneal decompensation (FDA Access Data)
Side Effects
  • Corneal swelling or edema, including bullous keratopathy, especially if corneal endothelium is traumatized or in diabetic eyes (DailyMed)
  • Postoperative inflammation, corneal clouding, or decompensation have been reported rarely (DailyMed)
Drug Interactions
  • No drug‑drug, drug‑food, or alcohol interactions, as BSS is not systemically absorbed
  • Additives are not recommended unless compatibly demonstrated; mixing with unapproved substances may damage ocular tissues (Drugs.com)
Recent Updates or Guidelines
  • Regulatory emphasis on single‑patient containers, no preservative, and maximum irrigation duration of 60 minutes (FDA Access Data)
  • BSS PLUS variant includes bicarbonate, dextrose, glutathione; used for longer intraocular procedures like vitrectomy, with improved retinal support and endothelial preservation (FDA Access Data)
  • No recent changes in core composition or new systemic safety warnings have emerged
Storage Conditions
  • Temperature: Store at 20 °C to 25 °C (68 °F to 77 °F); excursions permitted to 15 °C–30 °C (59 °F–86 °F) (MedLibrary.org)
  • Humidity & Light: Store in original overwrap to protect from light and humidity
  • Freezing: Do not freeze
  • Handling: Use only if overwrap intact, container clear, seal unbroken; follow aseptic technique. Discard unused portion immediately after opening; do not reuse container (MedLibrary.org)
Available Brand Names